Founded with the core mission of providing custom medicines for dermatologists, Sincerus Pharmaceuticals aims to ensure patients receive trusted, tailored treatments without unnecessary excipients. The company focuses on dermatological needs, offering a range of personalized skincare products including post-treatment creams, pigment correctors, and sun protection factors. Sincerus leverages telehealth services to deliver these specialized treatments directly to patients' doors, enhancing accessibility and convenience.
Sincerus Pharmaceuticals has garnered attention for its innovative approach to personalized medicine in dermatology. While specific notable affiliated people and investors are not detailed, the company's impact is evident through its commitment to improving patient outcomes with customized solutions. By eliminating hidden fees and partnering with local dermatologists, Sincerus has made significant strides in telehealth, ensuring better skin health for a broader audience.
Quick Facts
When was Sincerus Pharmaceuticals' last funding round?
Sincerus Pharmaceuticals' most recent funding round was for $505.5k (USD) in March 2019.
How much disclosed funding has Sincerus Pharmaceuticals raised?
As of Mar 13, 2019, Sincerus Pharmaceuticals has disclosed funding of $505.5k (USD).